EMEA-003301-PIP01-22-M01 - paediatric investigation plan
interleukin-23 receptor antagonist peptide
PIPHuman
Key facts
- Active Substance
- interleukin-23 receptor antagonist peptide
- Therapeutic area
- Dermatology
- Decision number
- P/0512/2023
- PIP number
- EMEA-003301-PIP01-22-M01
- Pharmaceutical form(s)
- Age-appropriate formulation
- Film-coated tablet
- Condition(s) / indication(s)
- Treatment of psoriasis
- Route(s) of administration
- Oral use
- Contact for public enquiries
- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date